ANIX – anixa biosciences, inc. (US:NASDAQ)
Stock Stats
News
4/1
08:00 am
anix
Medium
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
3/26
08:19 am
anix
Medium
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
3/25
08:27 am
anix
Medium
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines [Yahoo! Finance]
3/25
08:17 am
anix
Medium
Anixa Biosciences, Inc. (NASDAQ: ANIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/25
08:00 am
anix
Medium
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
3/11/2025
04:20 pm
ANIX
0.8%
IN-LINE
3/11/2025
04:20 pm
ANIX
0.8%
IN-LINE
3/11/2025
04:20 pm
ANIX
0.8%
IN-LINE
3/11/2025
04:20 pm
ANIX
0.8%
IN-LINE
3/25
08:17 am
Reiterates
Buy
Buy
HC Wainwright
Medium
-7.1%
3/21
08:46 am
Initiates
Buy
Maxim Group
Low
-0.3%
3/21
08:15 am
Initiates
Buy
Maxim Group
Low
-0.3%
3/21
08:15 am
Initiates
Buy
Maxim Group
Low
-0.3%
3/21
08:00 am
Initiates
BUY
MAXIM
Low
-0.3%
3/21
04:16 pm
anix
Low
Form 8-K Anixa Biosciences Inc For: Mar 20
3/11
04:20 pm
anix
Low
Form 10-Q Anixa Biosciences Inc For: Jan 31
2/6
04:15 pm
anix
Low
Form DEF 14A Anixa Biosciences Inc For: Oct 31
1/29
10:06 am
anix
Medium
Form 4 Anixa Biosciences Inc For: Jan 28 Filed by: Baskies Arnold M
1/27
09:14 am
anix
Low
Form 4 Anixa Biosciences Inc For: Jan 23 Filed by: Titterton Lewis H jr
Show more
Top News Gainers
7/17 Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology 13.1%
12/30 ITUS Corporation (NYSE: ANIX) had its price target lowered by analysts at B. Riley from $11.25 to $8.00. They now have a "buy" rating on the stock. 11.8%
1/14 Form 4 Anixa Biosciences Inc For: Jan 14 Filed by: KUMAR AMIT 10.4%
11/26 Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study 7.3%
1/16 Form 4 Anixa Biosciences Inc For: Jan 15 Filed by: Titterton Lewis H jr 6.9%
10/15 Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts 5.7%
12/23 Anixa Biosciences to Present at Biotech Showcase 2020 5.5%
4/27 ITUS Corporation (NYSE: ANIX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 4.8%
1/21 Form 4 Anixa Biosciences Inc For: Jan 17 Filed by: Baskies Arnold M 4.8%
8/21 Form 8-K Anixa Biosciences Inc For: Aug 21 4.6%
Top News Decliners
3/9 Q1/2020 1/31/2020 EPS -0.130 ZacksConsensus -0.130 ActVsEst 0.000 - In-Line -18.5%
12/13 Anixa Biosciences Provides Update on CAR-T Program -15.1%
4/20 Anixa Bio up 30% premarket on plan to develop COVID-19 drugs [Seeking Alpha] -12.6%
1/1 ITUS Corporation (NYSE: ANIX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.50 price target on the stock. -8.5%
3/23 ITUS Corporation (NYSE: ANIX) is now covered by analysts at Aegis. They set a "buy" rating and a $8.50 price target on the stock. -6.1%
3/24 ITUS Corporation (NYSE: ANIX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.0%
7/18 Form 8-K Anixa Biosciences Inc For: Jul 12 -4.4%
6/11 Form S-3 Anixa Biosciences Inc -3.6%
1/10 Form 10-K/A Anixa Biosciences Inc For: Oct 31 -3.5%
4/20 ITUS Corporation (NYSE: ANIX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $2.25 price target on the stock. -3.4%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3